Full Text View
Tabular View
No Study Results Posted
Related Studies
The Effects of Sorafenib on Molecular Barrett's Esophagus Cancer
The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2009 by University of Chicago.
Recruitment status was  Recruiting
Study NCT00619242   Information provided by University of Chicago

First Received on February 6, 2008.   Last Updated on February 13, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Esophageal Cancer
Additional conditions recognized in this trial
Barrett Esophagus
Esophageal Diseases
Esophageal Neoplasms
More general conditions related to this trial
Digestive System Abnormalities
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Head and Neck Neoplasms
Neoplasms
Neoplasms by Site
Interventions listed in this trial
sorafenib
More general drug interventions related to this trial
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Kinase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
University of Chicago
Bayer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services